• 1
    Pocock SJ. Clinical Trials. A Practical Approach. New York , NY : John Wiley & Sons; 1983.
  • 2
    Cochran WG. Research techniques in the study of human beings. MilbankQ 1955;23:121136.
  • 3
    Hill AB. Observation and experiment. N Engl J Med 1953;248:9951001.
  • 4
    Davis CE. The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol 1976;104:493498.
  • 5
    Roethlisberger F., Dickson WJ, Wright HA. Management and the Worker. Cambridge, MA; 1964.
  • 6
    Smith RD. Veterinary clinical research: A survey of study designs and clinical issues appearing in a practice journal. J Vet Med Educ 1988;15:27.
  • 7
    Hills M. The two-period cross-over clinical trial. Br J Clin Pharmacol 1979;8:720.
  • 8
    Meinert C. Clinical Trials. Design, Conduct and Analysis. New York , NY : Oxford University Press; 1986.
  • 9
    Armitage P. The role of randomization in clinical trials. Stat Med 1982;1:345352.
  • 10
    Zelen M. The randomization and stratification of patients to clinical trials. J Chronic Dis 1974;27:365375.
  • 11
    Prentice RL. Surrogate endpoints in clinical trials: Definition and operational criteria. Stat Med 1989;8:431440.
  • 12
    Echt DS, Liebsan PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainamide, flecamide, a placebo. N EnglJMed 1991;324:781788.
  • 13
    Friedman LM, Fuberg CD, DeMets DL. Fundamentals of Clinical Trials. Boston , MA : John Wright Publishing; 1982.
  • 14
    Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials 1981;2:93113.
  • 15
    Brahman LE. Confidence intervals assess both clinical significance and statistical significance. Ann Intern Med 1991;114:515517.
  • 16
    Freiman JA, Chalmers TC, Smith H. Jr, et al. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. N Engl J Med 1978;299:690694.
  • 17
    Fisher LD, Dixon DO, Hereon J., et al. Intention to treat in clinical trials. Peace KE, ed. Statistical Issues in Drug Development. 1990;331350.
  • 18
    Chalmers TC, Smith H. Jr, Blackburn B., et al. A method for assessing the quality of a randomized control trial. Control Clin Trials 1981;2:3149.
  • 19
    Bailar JC III, Mosteller F. Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations. Ann Intern Med 1988;108: 266273.
  • 20
    O'Fallon JR, Dubey SD, Salsburg DS, et al. Should there be statistical guidelines for medical research papers Biometrics 1978;34:687695.
  • 21
    International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 1991;324:424428.
  • 22
    Neaton JD. Facilitating critical evaluation of clinical trial reports. Annual Meeting of the Council of Biology Editors, Rochester, MN; 1989.
  • 23
    DerSimonian R., Charette LJ, McPeek B., et al. Reporting on methods in clinical trials. N Engl J Med 1982;306:13321337.
  • 24
    Mosteller F., Gilbert JP, McPeek B. Reporting standards and research strategies for controlled trials. Control Clin Trials 1980;1:3758.